Cosmo Bio Company Ltd operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cosmo Bio Company Ltd with three other
drug stores in Asia:
New Ray Medicine International Holding Ltd
of Hong Kong
sales of 372.44 million Hong Kong Dollars [US$47.49 million]
PharmaBlock Sciences Nanjing Inc
(478.25 million Chinese Renmimbi [US$71.26 million]
of which 32%
was Aromatic Heterocyclic Series Drug Molecu), and
Excelsior Biopharma Inc
based in Taiwan
(1.69 billion Taiwanese Dollars [US$54.73 million]
Cosmo Bio Company Ltd reported sales of ¥7.26 billion (US$64.84 million)
December of 2018.
increase of 2.7%
versus 2017, when the company's sales were ¥7.07 billion.
Despite this increase, sales are still
below the level achieved in 2016, when Cosmo Bio Company Ltd
reported sales of ¥7.43 billion.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Cosmo Bio Company Ltd had sales
of ¥7.05 billion.